ARDX CIK: 1437402

Ardelyx Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.10
FY22:
48.0
FY23:
107
FY24:
283
FY25:
368
(positive)
Change from FY21 to FY25
millions USD
FY21:
−153
FY22:
−59.6
FY23:
−63.3
FY24:
−28.0
FY25:
−41.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−151
FY22:
−61.0
FY23:
−55.4
FY24:
−16.7
FY25:
−29.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−158
FY22:
−67.2
FY23:
−65.5
FY24:
−38.9
FY25:
−60.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−158
FY22:
−67.2
FY23:
−66.1
FY24:
−39.1
FY25:
−61.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data